Critical Values - January 2009 - (Page 25) Communication Pap and HPV: Two Perspectives The introduction of the human papillomavirus (HPV) test and HPV vaccine has changed the landscape for cervical cancer screening. This change affects many—patients, clinicians, laboratory directors, test and vaccine manufacturers, the cytotechnologists who read Pap smears, the schools that educate cytotechnologists, and the agency that certifies them. Rapidly emerging science, vested interests, and conflicting news reports muddy the view of the road ahead. And experts differ on the nature and pace of change. No single message encapsulates this issue. On the following pages Critical Values presents the view of the landscape from two vantage points. 25
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.